TRUE Private Wealth Advisors Purchases 458 Shares of The Clorox Company (NYSE:CLX)

TRUE Private Wealth Advisors increased its holdings in The Clorox Company (NYSE:CLX) by 12.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,121 shares of the company’s stock after buying an additional 458 shares during the period. TRUE Private Wealth Advisors’ holdings in Clorox were worth $588,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. International Assets Investment Management LLC raised its position in Clorox by 17,658.5% during the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after purchasing an additional 481,725 shares in the last quarter. Adage Capital Partners GP L.L.C. acquired a new position in Clorox during the third quarter valued at approximately $6,605,000. Eagle Rock Investment Company LLC acquired a new position in Clorox during the fourth quarter valued at approximately $2,940,000. Nordea Investment Management AB raised its position in Clorox by 4.0% during the fourth quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock valued at $1,362,000 after purchasing an additional 364 shares in the last quarter. Finally, Teacher Retirement System of Texas raised its position in Clorox by 742.8% during the third quarter. Teacher Retirement System of Texas now owns 78,713 shares of the company’s stock valued at $10,316,000 after purchasing an additional 69,373 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of NYSE CLX opened at $142.29 on Thursday. The firm’s 50-day moving average price is $150.40 and its 200-day moving average price is $141.69. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $178.21. The firm has a market capitalization of $17.66 billion, a P/E ratio of 225.86, a P/E/G ratio of 2.22 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the business earned $0.98 earnings per share. The business’s quarterly revenue was up 16.0% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be issued a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.37%. Clorox’s dividend payout ratio is presently 761.92%.

Analysts Set New Price Targets

A number of research firms have weighed in on CLX. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research note on Tuesday, March 26th. DA Davidson reaffirmed a “neutral” rating and set a $162.00 target price on shares of Clorox in a research note on Wednesday. Citigroup decreased their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research note on Thursday, January 18th. Finally, UBS Group boosted their price objective on shares of Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, February 2nd. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $148.63.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.